Radiofrequency Ablation
Device35 Patients will be undergo for radiofrequency ablation which will be applied to each genicular nerve.
NCT Number: NCT06798038
Chronic knee pain is a common condition that affects many people, particularly those with knee osteoarthritis. It can limit mobility, reduce the quality of life, and increase the risk of falling .
There are various treatment options for chronic knee osteoarthritis pain, including medications, physical therapy and surgery. Topical and oral analgesic medications and physical therapy, are often used in this population but with variable success and often wanting pain relief over time as the condition progresses.
Patients who fail medical treatment often undergo total knee arthroplasty (TKA) However, there are significant comorbidities associated with TKA, and most of patients suffer with chronic knee pain after this surgery Furthermore, a subset of patients are unable to undergo TKA because of medical comorbidities.
One alternative treatment option is genicular nerve ablation, which involves destroying nerves that carry pain signals from the knee joint to the brain. Genicular nerve ablation can be performed using radiofrequency ablation (RFA) or chemical agents such as phenol. Both methods aim to provide long-term pain relief and functional improvement in patients with chronic knee pain(4).
Chemical neurolytics, such as alcohol or phenol, have come to the fore because of their low cost and ease of application compared to radiofrequency ablation.These methods can be easily applied with ultrasound (US) guidance, which allows precise targeting of the relevant nerves. However, there is a lack of literature on appropriate agents and dose selection issues .
Radiofrequency neurolysis (RFN) of the genicular nerves, which provides innervation to the capsule of the knee joint, as well as to the intra-articular and extra-articular ligaments, have been of considerable interest as an effective technique to alleviated knee osteoarthritis pain .However, it requires expensive specialized equipment and trained personnel, which may not be available or affordable in some settings.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Phase 1
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
35 Patients will be undergo for radiofrequency ablation which will be applied to each genicular nerve.
35 Patients will be administered with 2.0 ml of 6% phenol solution prepared from crystallized phenol per genicular nerve
35 Patients will be administered with 1.0ml of 70% alcohol per genicular nerve
Time frame: immediately after intervention , 1 week,1month,3 months,6months and one year.
Time frame: immediately after intervention , 1 week,1month,3 months,6months and one year.
Time frame: immediately after intervention , 1 week,1month,3 months,6months and one year.
Contact information is provided by the study sponsor or research team.
Tanta University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07738627
Arthritis, Joint Diseases
Rawalpindi, Punjab Province, Pakistan
View Trial DetailsNCT07736352
ASA Class I/II Patients, Arthritis
View Trial DetailsNCT07703280
Arthritis, Joint Diseases
Chiayi City, Taiwan
View Trial DetailsNCT07698418
Arthritis, Chronic Pain
View Trial Details